Stress · 2008 · 78 citations · 33 references
Life SciencesImmunologyOncologyCancer ImmunologyPsychoneuroimmunologyTumor ImmunologyCell-mediated ImmunityCytotoxic T Lymphocyte ResponsesImmune RegulationStress-immune InteractionsT Cell BiologyTumor-infiltrating LymphocytesCell-mediated Immunity ImpairmentChronic StressImmune System DisruptionRestraint StressStress-induced Immune ResponseStressful ExperienceT-cell Mediated ImmunityTumor Cell Proliferation
Long-term exposure to stressful situations can affect the immune system. The T-cell response is an important component of anti-tumoral immunity. Hence, impairment of the immune function induced by a chronic stressor has been postulated to alter the immunosurveillance of tumors, thus leading to a worse neoplastic prognosis. Here, we show that chronic restraint stress affects T-cell mediated immunity in mice. This was evidenced by a decrease of mitogen-induced T-cell proliferation, a reduction in CD4(+)T lymphocyte number and a decrease of tumor necrosis factor-alpha (TNF-alpha) and Interferon-gamma (IFN-gamma) production in stressed mice. Additionally, mice subjected to chronic restraint stress displayed an enhancement of tumor growth in a syngeneic lymphoma model, i.e. an increase of tumor proliferation and a reduction of animal survival. Finally, stressed mice had a reduced specific cytotoxic response against these tumor cells. These results suggest that chronic exposure to stress promotes cancer establishment and subsequent progression, probably by depressing T-cell mediated immunity. The T-cell immunity impairment as well as the tumor progression enhancement emphasize the importance of the therapeutic management of stress to improve the prognosis of cancer patients.
33
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Premal H. Thaker, Liz Y. Han, Aparna A. Kamat et al. · Nature Medicine · 2006 · 1.3K citations
Medicine, Cancer Biology, Oncology +16
Psychoneuroendocrine Influences on Immunocompetence and Neoplasia
Vernon Riley · Science · 1981 · 758 citations
CD4 cells can be more efficient at tumor rejection than CD8 cells
Ainhoa Pérez‐Díez, Nathalie T. Joncker, Kyungho Choi et al. · Blood · 2007 · 421 citations · Full text
Life Sciences, Immunology, Oncology +16
Alain H. Rook, Gary S. Wood, Elisa K. Yoo et al. · Blood · 1999 · 276 citations
Medicine, Immunology, Oncology +14